US Stock MarketDetailed Quotes

Nuvectis Pharma (NVCT)

Watchlist
  • 12.040
  • +1.140+10.46%
Close May 13 16:00 ET
  • 12.040
  • 0.0000.00%
Post 16:48 ET
319.37MMarket Cap-9.19P/E (TTM)

Nuvectis Pharma (NVCT) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
12.43%6.26M
38.93%27.57M
18.11%7.62M
78.80%7.79M
42.04%6.6M
26.66%5.57M
-13.32%19.85M
-6.07%6.45M
-29.21%4.36M
-19.56%4.64M
Selling and administrative expenses
14.09%2.15M
35.96%9.42M
29.60%2.53M
31.17%2.02M
75.41%2.98M
8.76%1.89M
-7.82%6.93M
-24.91%1.95M
-7.89%1.54M
12.58%1.7M
-General and administrative expense
14.09%2.15M
35.96%9.42M
29.60%2.53M
31.17%2.02M
75.41%2.98M
8.76%1.89M
-7.82%6.93M
-24.91%1.95M
-7.89%1.54M
12.58%1.7M
Research and development costs
11.58%4.11M
40.52%18.15M
13.12%5.09M
104.82%5.77M
22.77%3.61M
38.35%3.68M
-16.01%12.92M
5.42%4.5M
-37.16%2.82M
-30.95%2.94M
Operating profit
-12.43%-6.26M
-38.93%-27.57M
-18.11%-7.62M
-78.80%-7.79M
-42.04%-6.6M
-26.66%-5.57M
13.32%-19.85M
6.07%-6.45M
29.21%-4.36M
19.56%-4.64M
Net non-operating interest income expense
-11.02%210K
33.65%1.13M
50.75%303K
61.17%332K
21.40%261K
4.89%236K
32.97%847K
-17.62%201K
-25.63%206K
235.94%215K
Non-operating interest income
-11.02%210K
33.65%1.13M
50.75%303K
61.17%332K
21.40%261K
4.89%236K
32.97%847K
-17.62%201K
-25.63%206K
235.94%215K
Other net income (expense)
Income before tax
-13.47%-6.05M
-39.17%-26.44M
-17.06%-7.31M
-79.68%-7.46M
-43.04%-6.33M
-27.84%-5.33M
14.65%-19M
5.65%-6.25M
29.38%-4.15M
22.42%-4.43M
Income tax
Net income
-13.47%-6.05M
-39.17%-26.44M
-17.06%-7.31M
-79.68%-7.46M
-43.04%-6.33M
-27.84%-5.33M
14.65%-19M
5.65%-6.25M
29.38%-4.15M
22.42%-4.43M
Net income continuous Operations
-13.47%-6.05M
-39.17%-26.44M
-17.06%-7.31M
-79.68%-7.46M
-43.04%-6.33M
-27.84%-5.33M
14.65%-19M
5.65%-6.25M
29.38%-4.15M
22.42%-4.43M
Minority interest income
Net income attributable to the parent company
-13.47%-6.05M
-39.17%-26.44M
-17.06%-7.31M
-79.68%-7.46M
-43.04%-6.33M
-27.84%-5.33M
14.65%-19M
5.65%-6.25M
29.38%-4.15M
22.42%-4.43M
Preferred stock dividends
Other preferred stock dividends
2.43M
0
2.43M
0
0
0
Net income attributable to common stockholders
-13.47%-6.05M
-51.95%-28.87M
-17.06%-7.31M
-138.17%-9.89M
-43.04%-6.33M
-27.84%-5.33M
14.65%-19M
5.65%-6.25M
29.38%-4.15M
22.42%-4.43M
Basic earnings per share
3.70%-0.26
-18.92%-1.32
13.89%-0.31
-83.33%-0.44
-15.38%-0.3
-8.00%-0.27
22.38%-1.11
12.20%-0.36
35.14%-0.24
31.58%-0.26
Diluted earnings per share
3.70%-0.26
-18.92%-1.32
13.89%-0.31
-83.33%-0.44
-15.38%-0.3
-8.00%-0.27
22.38%-1.11
12.20%-0.36
35.14%-0.24
31.58%-0.26
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 12.43%6.26M38.93%27.57M18.11%7.62M78.80%7.79M42.04%6.6M26.66%5.57M-13.32%19.85M-6.07%6.45M-29.21%4.36M-19.56%4.64M
Selling and administrative expenses 14.09%2.15M35.96%9.42M29.60%2.53M31.17%2.02M75.41%2.98M8.76%1.89M-7.82%6.93M-24.91%1.95M-7.89%1.54M12.58%1.7M
-General and administrative expense 14.09%2.15M35.96%9.42M29.60%2.53M31.17%2.02M75.41%2.98M8.76%1.89M-7.82%6.93M-24.91%1.95M-7.89%1.54M12.58%1.7M
Research and development costs 11.58%4.11M40.52%18.15M13.12%5.09M104.82%5.77M22.77%3.61M38.35%3.68M-16.01%12.92M5.42%4.5M-37.16%2.82M-30.95%2.94M
Operating profit -12.43%-6.26M-38.93%-27.57M-18.11%-7.62M-78.80%-7.79M-42.04%-6.6M-26.66%-5.57M13.32%-19.85M6.07%-6.45M29.21%-4.36M19.56%-4.64M
Net non-operating interest income expense -11.02%210K33.65%1.13M50.75%303K61.17%332K21.40%261K4.89%236K32.97%847K-17.62%201K-25.63%206K235.94%215K
Non-operating interest income -11.02%210K33.65%1.13M50.75%303K61.17%332K21.40%261K4.89%236K32.97%847K-17.62%201K-25.63%206K235.94%215K
Other net income (expense)
Income before tax -13.47%-6.05M-39.17%-26.44M-17.06%-7.31M-79.68%-7.46M-43.04%-6.33M-27.84%-5.33M14.65%-19M5.65%-6.25M29.38%-4.15M22.42%-4.43M
Income tax
Net income -13.47%-6.05M-39.17%-26.44M-17.06%-7.31M-79.68%-7.46M-43.04%-6.33M-27.84%-5.33M14.65%-19M5.65%-6.25M29.38%-4.15M22.42%-4.43M
Net income continuous Operations -13.47%-6.05M-39.17%-26.44M-17.06%-7.31M-79.68%-7.46M-43.04%-6.33M-27.84%-5.33M14.65%-19M5.65%-6.25M29.38%-4.15M22.42%-4.43M
Minority interest income
Net income attributable to the parent company -13.47%-6.05M-39.17%-26.44M-17.06%-7.31M-79.68%-7.46M-43.04%-6.33M-27.84%-5.33M14.65%-19M5.65%-6.25M29.38%-4.15M22.42%-4.43M
Preferred stock dividends
Other preferred stock dividends 2.43M02.43M000
Net income attributable to common stockholders -13.47%-6.05M-51.95%-28.87M-17.06%-7.31M-138.17%-9.89M-43.04%-6.33M-27.84%-5.33M14.65%-19M5.65%-6.25M29.38%-4.15M22.42%-4.43M
Basic earnings per share 3.70%-0.26-18.92%-1.3213.89%-0.31-83.33%-0.44-15.38%-0.3-8.00%-0.2722.38%-1.1112.20%-0.3635.14%-0.2431.58%-0.26
Diluted earnings per share 3.70%-0.26-18.92%-1.3213.89%-0.31-83.33%-0.44-15.38%-0.3-8.00%-0.2722.38%-1.1112.20%-0.3635.14%-0.2431.58%-0.26
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More